<DOC>
	<DOCNO>NCT00265629</DOCNO>
	<brief_summary>This early feasibility trial design demonstrate whether new ablation device use safely effectively treat atrial fibrillation . This study prospective , nonrandomized , single-arm , multi-center trial conduct single study site</brief_summary>
	<brief_title>RF Ablation Atrial Fibrillation</brief_title>
	<detailed_description>This study intend evaluate safety preliminary effectiveness RFMesh BAS electrophysiological mapping radiofrequency ablation region ostium target pulmonary vein treatment drug refractory paroxysmal atrial fibrillation .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Patients 18 &amp; 85 year age . 2 . Patients minimum 2 episode symptomatic PAF within last 6 month prior baseline evaluation . At least one episodes must document . Documentation may include electrocardiogram ( ECG ) , trans telephonic monitoring ( TTM ) , Holter monitoring ( HM ) , telemetry strip . Additional PAF episode ( i.e. , verbal account patient ) document patient 's study record . 3 . Patients fail least 1 class I class III antiarrhythmic medication regimen . 4 . Patients ability understand requirement study , provide write informed consent agree study restriction return require followup assessment . 1 . Any previous ablation leave atrium ( surgical catheter base ) . 2 . Permanent persistent atrial fibrillation . 3 . Recent myocardial infarction within 2 month 4 . Currently unstable angina . 5 . Any cardiac surgery previous 3 month . 6 . Currently document intracardiac thrombus transesophageal echocardiography ( TEE ) . 7 . A left atrium &gt; 50mm major dimension . 8 . A common ostium large 25 mm major axis individual pulmonary vein large 25 mm major axis . 9 . Permanent lead right atrium . 10 . Clinically significant valvular heart disease replacement heart valve . 11 . Congestive heart failure ( NYHA classification III IV ) . 12 . An ejection fraction &lt; 35 % . 13 . A contraindication warfarin . 14 . A contraindication transseptal procedure . 15 . Any cerebral ischemic event , include transient ischemic attack ( TIA ) , precede 6 month . 16 . Any known bleeding disorder . 17 . Women know pregnant nursing . 18 . Uncontrolled hyperthyroidism . 19 . Patients currently enrol clinical investigation . 20 . Any significant uncontrolled unstable medical condition . 21 . A life expectancy le one year . 22 . Currently take amiodarone take amiodarone within 4 month prior baseline evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Atrial fibrillation</keyword>
</DOC>